Pathstone Family Office, LLC Bio N Tech Se Call Options Transaction History
Pathstone Family Office, LLC
- $15.6 Billion
- Q3 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BNTX
# of Institutions
327Shares Held
40.4MCall Options Held
1.31MPut Options Held
1.37M-
Baillie Gifford & CO8.36MShares$669 Million0.61% of portfolio
-
Primecap Management CO Pasadena, CA4.81MShares$385 Million0.34% of portfolio
-
Harding Loevner LP Bridgewater, NJ3.82MShares$306 Million2.24% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M3.47MShares$278 Million1.4% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U03.43MShares$275 Million1.76% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $19.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...